Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine

Biochem Pharmacol. 2000 Apr 1;59(7):887-90. doi: 10.1016/s0006-2952(99)00396-2.

Abstract

To investigate the effect of metformin on intestinal glucose absorption, a perfusion study of the intestine was performed in the rat. Male Wistar albino rats (8 weeks old) were used in the present study. The glucose absorption by the perfused intestine (788.1+/-81.9 micromol/30 min) was not changed significantly by the direct addition of metformin (90 microg/mL) to the perfusing medium (737.0+/-118.2 micromol/30 min) or by intraduodenal metformin (250 mg/kg in saline solution) infusion (772.8+/-106.3 micromol/30 min). In rats orally administered metformin (250 mg/kg) for 5 days, glucose absorption by the perfused intestine (375.0+/-164.3 micromol/30 min) was significantly (P<0.001) lower than that in control rats (811.0+/-83.1 micromol/30 min). These results indicate that metformin had a significant effect on the digestive tract, and that metformin treatment exerted an inhibitory effect on intestinal glucose absorption in the rat.

MeSH terms

  • Animals
  • Glucose / metabolism*
  • Hypoglycemic Agents / pharmacology
  • In Vitro Techniques
  • Intestinal Absorption / drug effects*
  • Male
  • Metformin / pharmacology*
  • Perfusion
  • Rats
  • Rats, Wistar

Substances

  • Hypoglycemic Agents
  • Metformin
  • Glucose